Available to buy in the UK from Peptides Lab UK, 5-Amino-1MQ is one of the most extensively characterised selective NNMT inhibitors in current metabolic research, with published pre-clinical evidence spanning adipocyte biology, diet-induced obesity models, NAD+/SAM pathway studies, skeletal muscle function research, and cancer cell biology
The trial was overseen and sponsored by Novo Nordisk
The legitimate supply contracted
Several trials on other NMDA-modulating drugs, including ketamine, 504 riluzole, 44,505 and d-cycloserine, 506 have been negative for the primary endpoint, indicating that further studies with increased sample sizes are required
[15] Animal studies in vivo An in vivo study in aging mice found that epitalon treatment significantly reduced the incidence of chromosomal aberrations, both for wild-type mice and for mice characterized by an accelerated aging phenotype, which is consistent with increases in telomere length
Heat degrades it
